Skip to main content

About Study Course

Department: Department of Public Health and Epidemiology
Credit points / ECTS:1 / 1.5
Course supervisor:Ilze Jākobsone
Study type:Full time
Course level:Bachelor
Target audience:Public Health
Language:Latvian
Branch of science:Clinical Medicine; Dermatology and Venereology

Objective

To demonstrate the variety and diversity of skin and venereal diseases, and their relation to the quality of life, as well as the disputed and changing meaning of these diseases in the society and its impact on an individual’s health. Particular attention will be paid to the aetiology, spread, infection routes and transfer possibilities, as well as skin disease characteristics, immunosuppression, and impact of addictive substances as alcohol and drugs, and the resulting impact on public health. Aesthetic dermatology as an important part of public health.

Prerequisites

Biology, anatomy, histology, biochemistry, parasitology, physiology, epidemiology, microbiology, virology, immunology, pharmacology, infectious and internal diseases.

Learning outcomes

Knowledge

The student will know the epidemiology of skin and venereal diseases and their role in public health; the student will be able to describe and analyse cases in dermatovenereology; will be able to characterise the spreading of chronic skin conditions, formulate their importance for public health.

Skills

The student will know how to draft an action plan for healthcare institutions in cases of skin and venereal diseases; The student will be able to analyse documents intended for the restriction of spreading of venereal diseases.

Competence

The student will be able to analyse epidemiologic data, acquired from the EU, WHO and other important organisations, and will be able to provide with information on epidemiologic situation in the world; the student will be able to analyse use or application of aesthetic dermatology and the importance of achieved results in public health.

Study course planning

Course planning not avalible right now.